Omega 3 Fatty Acids in Patients With Chronic Renal Disease

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT03280615

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
University of Chile (from the registry)
Registry
  • NCT NCT03280615
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Chile (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03280615. Randomized; triple masking; primary purpose treatment. Start 2017-09-20 (actual); primary completion 2018-10-31 (actual). Results posted on 2019-09-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Omega 3 Fatty Acids in Patients With Chronic Renal Disease
Condition
Renal Insufficiency, Chronic
Intervention (Dietary supplement)
Omega 3 fatty acids
Intervention (Dietary supplement)
Corn oil
Lead sponsor
University of Chile (class: other)
Collaborator
Servicio de Salud Metropolitano Sur Oriente (class: other government)

Record details

Record id
cardio:ct-nct03280615
Content hash
705ca3bea1c6552ba9d54ce4afc017a023dc9574ef2b8f7460d5a18ce0ccaefb